RainDance Technologies, Inc.
RainDance Technologies, Inc. (RDT) is engaged in the development of microfluidic instruments and nanoreactors for the in-vitro diagnostic markets. Its major product is the professional laboratory system which is used in laboratories and research centres for automation of data-rich assays and screening protocols. Its technology is used in the detection of cancer cells in the blood and for improved enzyme eveolution. It also develops nanoreactor chips that are used in RNAi screening, enzyme profiling, screening and on-chip chemical synthesis. The company is headquartered in Connecticut, the US.
On September 18, 2009, the company entered into a collaboration with CLC bio to develop specialized software solutions for analysis of targeted resequencing data.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

